Four novel cyclic pentapeptides, designated plactins A, B, C and D, were isolated by solvent extraction and reverse-phase HPLCfrom myceliumof a fungal strain F165 that belongs to the order ofAgonomycetales. By a combination of chemical and spectroscopic analyses and chemical synthesis, the structures of plactins A, B, C and D were determined to be cyclo(~D-Ya\-L-LQu-D-allol\e-L-
Arg~) and c^cZo(-D-Val-L-Leu-D-Leu-L-Phe-D-Arg-),
respectively. Plactins stimulated U937 cellmediated degradation of 125I-fibrin plates by 50% at a concentration of 1.5~32 um.
Vascular endothelial cells play a crucial role in
thromboregulation by virtue of a membrane-oriented fibrinolytic system. Cell-surface binding of fibrinolytic components, plasminogen and its activators, provide a mechanism for local regulation of fibrinolysis^40. During the course of searching for microbial metabolites that stimulate cell-mediated fibrinolysis, we have found four novel cyclic pentapeptides as active compounds. The present paper describes the isolation, structural characterization and biological activity of these metabolites.
Materials and Methods
Materials RPMI-1640 medium was purchased from Gibco and fetal bovine serum from Irvine Scientific, U.S.A. Carrierfree Na125I was a product of Amersham. Human fibrinogen and thrombin were obtained from Sigma.
9-Fluorenylmethoxycarbonyl-amino acids (Fmoc-amino acids), 2-chlorotrithylchloride-resin, benzotriazol-1 -yloxy-tris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP) and 1-hydroxybenzotriazole (HOBt) were purchased from Shimadzu Co., Japan. 9-Fluorenylmethyl 7V-succinimidyl carbonate (Fmoc-ONSu) was obtained from Peptide Institute, Japan, and 7V-methylmorpholine (NMM)from Wako Pure Chemical, Japan.
Fmoc-D-a/Mle was prepared from Fmoc-ONSu and D-alloI\e as described by Milton et al5) Human venous blood was drawn from healthy volunteers in 13mM sodium citrate and centrifuged at 2,000 x g for 1 5 minutes at 4°C. The resulting platelet-poor plasma was stored at -80°C until use. Fibrinogen was radioiodinated by the iodine monochloride method6) to a specific activity of 200~400 cpm/ng7).
Microorganism 45
The producing strain F165, a fungal strain belonging to Fungi Imperfecti, was isolated from a soil sample collected in Itsukaichi-machi, Tokyo and subcultured on potato glucose agar slants.
Synthesis of Cyclic Pentapeptides
Linear pentapeptides were synthesized according to the Fmoc chemistry using the PyBOP-HOBt-NMM system and 2-chlorotrithylchloride-resin as described by Nokihara et RPMI-1640 medium supplemented with 10% of fetal bovine serum, 100units/ml of penicillin and 100/ig/ml of streptomycin. For assays, cells were seeded at 1.5 x 105 cells/ml in 20 ml of the medium and grown for 2 days. Prior to use in experiments, cells were washedonce with buffer A (0.15m NaCl and 20him sodium phosphate, pH 7.4) and then suspended in buffer B (buffer A supplemented with 5 mg/ml calf skin gelatin).
Determination of Cellular Fibrinolytic Activity 125I-Fibrin plate were prepared in wells of a 96-well microplate as described previously7) using 125I-fibrinogen (~lOOOcpm/jUg). The 125I-fibrin plates were washed twice with 100fil of buffer A supplemented with 0.1% Tween 80 and then once with lOO/il of buffer A. The 125I-fibrin plates were then incubated at 37°C for 60 minutes in 200 fil of buffer B. After removing the buffer, the 125I-fibrin plates received 35fil of human citrated plasma and 35fil of buffer B containing U937 cells (7.5 x 106/ml) and test samples and incubated at 37°C with occasional mixing. A portion (35 fil) of the incubation mixture was withdrawn after 2 hours to determine radioactivity released from the 125I-fibrin plates.
General Procedures UV spectra were taken on a 320 spectrometer (Hitachi, Japan). IR spectra were recorded on a Hitachi IR-810 spectrometer. Mass spectra were taken on a JMS-SX102A (JEOL, Japan) and a ZAB-HF(VG, Great Britain) spectrometers. Amino acid composition was analyzed on a model 835 amino acid analyzer (Hitachi). Peptide sequence was determined using 477A and 470A protein sequencers and a 120A PTH analyzer (Applied Strain F165 was grown aerobically as described in the text. Onemilliliter aliquot of the cultured broth was removed everyday and lyophilized. The lyophilized material was extracted with 1 ml of90% aq. methanol, and 6-fA portions of the organic extracts were assayed in duplicate for the stimulation of cellular fibrinolysis.
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of the fermentation is shown in Fig. 1 , where the production of plactins was monitored by measuring stimulation of cellular fibrinolytic activity. The stimulating activity was produced after 4 days of cultivation, giving the maximumactivity on day 6. Isolation Mycelium of strain F165 obtained from ll liters of a 7-day culture was extracted with acetone (once with 3 liters and twice with 1.5 liters). The acetone extract was concentrated to 2 liters and kept overnight at 4°C. The precipitates formed were successively washed (twice with 1 liter of water and twice with 1 liter of ethyl acetate) 
Hetention time (minute)
A portion (22mg) of partially purified plactins was applied to a silica ODS column as described in the text. Elution was monitored by UV absorption at 220nm.
Positions where plactins eluted are marked by arrows. 47 and dried in vacuo. The resulting brownish powder (~5 g) was dissolved in 80 ml of hot methanol and subjected to preparative HPLCon an Inertsil PREP-ODScolumn (30 x 250, GLSciences) in multiple batches. The column was developed at 40°C with acetonitrile-0.1% aq.
phosphoric acid (32 : 68) at a rate of25 ml/minute. Four active fractions (Fig. 2) were collected and re-chromatographed under the same conditions. Active fractions were neutralized with 1 m NaOHand then acetonitrile in the fractions was removedby evaporation. The resulting aqueous solutions were kept overnight at 4°C and precipitates formed were collected by centrifugation. After washing with water, the precipitates were suspended in water and then lyophilized, giving 13.7, 85.6, 0.2 and 26.6 mg of purified plactins A, B, C and D, respectively.
Structure Elucidation
The physico-chemical properties of plactins are summarized in Table 1 respectively. Edmandegradation of plactins yielded no NH2-terminal amino acids. From these observations, molecular formulae ofplactins were determined as shown in Table 1 .
The structure of plactins were determined by sequence analysis of partial acid hydrolysates. Plactins were treated with 12m HC1 at 37°C for 24 hours. The resulting lysates were fractionated by HPLCon a silica ODScolumn and each fraction was subjected to FAB-MS analysis. showed that plactin B has the former structure. Similarly, structures of plactins A, C and D were identified to be
These results are summarized in Fig. 3 . JAN. 1996 Biological Activity When U937 cells were incubated with 125I-fibrin in a plasma milieu at 37°C for 4 hours, approximately 0.8 ng of 125I-fibrin was degraded. Plactins A, B, C and D potentiated this cellular fibrinolytic activity by 1.5-fold at concentrations of 32, 9.8, 24 and 7.5 jUM, respectively. At higher concentrations (30~50 fiM), the stimulation by plactins B and D ranged 3-to 4-fold.
Discussion
In the present study, we have isolated four novel cyclic pentapeptides, designated plactins A, B, C and D, as stimulators of cellular fibrinolytic activity. We had previously identified another activator of fibrinolysis.
This compound(complestatin) stimulates the binding of plasminogen to U937 cells and fibrin7). The mechanism of plactin stimulation of fibrinolysis seems to be different from that of complestatin, since plactins failed to enhance plasminogen binding (data not shown).
Amongfour plactins, plactin Dwas most potent in Thus, it is likely that D-Leu plays a key role in activating fibrinolysis. Results of detailed structure-activity study and the mechanismof action of plactins will be reported elsewhere.
